Exhibit 99.2
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Revenue | $ | 140,400 | $ | 125,317 | $ | 274,232 | $ | 238,079 | ||||||||
Cost of operations | 54,456 | 51,596 | 107,020 | 98,539 | ||||||||||||
Sales and marketing | 33,321 | 31,422 | 66,232 | 62,355 | ||||||||||||
General and administrative | 22,339 | 24,282 | 46,120 | 47,816 | ||||||||||||
Depreciation and amortization | 7,042 | 6,635 | 14,370 | 13,488 | ||||||||||||
Interest income | 17 | 17 | 32 | 38 | ||||||||||||
Interest expense | 6,172 | 5,832 | 12,344 | 11,664 | ||||||||||||
Other expense | — | 1,353 | — | 1,353 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income before income tax provision | 17,087 | 4,214 | 28,178 | 2,902 | ||||||||||||
Income tax provision | 7,371 | 1,603 | 12,196 | 1,829 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | 9,716 | $ | 2,611 | $ | 15,982 | $ | 1,073 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Net income per common share: | ||||||||||||||||
Basic | $ | 0.26 | $ | 0.05 | $ | 0.41 | $ | 0.02 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted | $ | 0.23 | $ | 0.05 | $ | 0.38 | $ | 0.02 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Weighted-average shares outstanding used in computing income per common share: | ||||||||||||||||
Basic | 37,819 | 49,315 | 38,543 | 49,161 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted | 45,801 | 50,925 | 46,667 | 50,175 | ||||||||||||
|
|
|
|
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION
(In thousands, unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Revenue | ||||||||||||||||
Public portal advertising and sponsorship | $ | 116,212 | $ | 105,783 | $ | 225,415 | $ | 199,221 | ||||||||
Private portal services | 24,188 | 19,534 | 48,817 | 38,858 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 140,400 | $ | 125,317 | $ | 274,232 | $ | 238,079 | |||||||||
|
|
|
|
|
|
|
| |||||||||
Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”) (a) | $ | 37,917 | $ | 29,241 | $ | 71,183 | $ | 50,530 | ||||||||
Interest, taxes, non-cash and other items (b) | ||||||||||||||||
Interest income | 17 | 17 | 32 | 38 | ||||||||||||
Interest expense | (6,172 | ) | (5,832 | ) | (12,344 | ) | (11,664 | ) | ||||||||
Income tax provision | (7,371 | ) | (1,603 | ) | (12,196 | ) | (1,829 | ) | ||||||||
Depreciation and amortization | (7,042 | ) | (6,635 | ) | (14,370 | ) | (13,488 | ) | ||||||||
Non-cash stock-based compensation | (7,633 | ) | (11,224 | ) | (16,323 | ) | (21,161 | ) | ||||||||
Other expense | — | (1,353 | ) | — | (1,353 | ) | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | 9,716 | $ | 2,611 | $ | 15,982 | $ | 1,073 | ||||||||
|
|
|
|
|
|
|
|
(a) | See Annex A-Explanation of Non-GAAP Financial Measures. |
(b) | Reconciliation of Adjusted EBITDA to net income. |
WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
June 30, 2014 | December 31, 2013 | |||||||
(unaudited) | ||||||||
Assets | ||||||||
Cash and cash equivalents | $ | 781,311 | $ | 824,880 | ||||
Accounts receivable, net | 128,493 | 124,232 | ||||||
Prepaid expenses and other current assets | 16,141 | 13,243 | ||||||
Deferred tax assets | 13,172 | 13,620 | ||||||
|
|
|
| |||||
Total current assets | 939,117 | 975,975 | ||||||
Property and equipment, net | 61,301 | 64,884 | ||||||
Goodwill | 202,980 | 202,980 | ||||||
Intangible assets, net | 12,699 | 13,834 | ||||||
Deferred tax assets | 36,463 | 38,802 | ||||||
Other assets | 26,885 | 29,153 | ||||||
|
|
|
| |||||
Total Assets | $ | 1,279,445 | $ | 1,325,628 | ||||
|
|
|
| |||||
Liabilities and Stockholders’ Equity | ||||||||
Accrued expenses | $ | 57,668 | $ | 73,739 | ||||
Deferred revenue | 98,336 | 85,148 | ||||||
Liabilities of discontinued operations | 1,506 | 1,506 | ||||||
|
|
|
| |||||
Total current liabilities | 157,510 | 160,393 | ||||||
2.25% convertible notes due 2016 | 252,232 | 252,232 | ||||||
2.50% convertible notes due 2018 | 400,000 | 400,000 | ||||||
1.50% convertible notes due 2020 | 300,000 | 300,000 | ||||||
Other long-term liabilities | 21,235 | 22,103 | ||||||
Stockholders’ equity | 148,468 | 190,900 | ||||||
|
|
|
| |||||
Total Liabilities and Stockholders’ Equity | $ | 1,279,445 | $ | 1,325,628 | ||||
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
Six Months Ended | ||||||||
June 30, | ||||||||
2014 | 2013 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 15,982 | $ | 1,073 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 14,370 | 13,488 | ||||||
Non-cash interest, net | 2,256 | 2,163 | ||||||
Non-cash stock-based compensation | 16,323 | 21,161 | ||||||
Deferred income taxes | 2,803 | 856 | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | (4,261 | ) | 2,829 | |||||
Prepaid expenses and other, net | (2,668 | ) | (3,060 | ) | ||||
Accrued expenses and other long-term liabilities | (16,015 | ) | (10,665 | ) | ||||
Deferred revenue | 13,188 | 6,149 | ||||||
|
|
|
| |||||
Net cash provided by operating activities | 41,978 | 33,994 | ||||||
Cash flows from investing activities: | ||||||||
Purchases of property and equipment | (11,446 | ) | (7,367 | ) | ||||
|
|
|
| |||||
Net cash used in investing activities | (11,446 | ) | (7,367 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | 30,147 | 10,340 | ||||||
Cash used for withholding taxes due on stock-based awards | (10,339 | ) | (1,745 | ) | ||||
Purchases of treasury stock | (102,353 | ) | (1,281 | ) | ||||
Excess tax benefit on stock-based awards | 8,444 | 363 | ||||||
|
|
|
| |||||
Net cash (used in) provided by financing activities | (74,101 | ) | 7,677 | |||||
|
|
|
| |||||
Net (decrease) increase in cash and cash equivalents | (43,569 | ) | 34,304 | |||||
Cash and cash equivalents at beginning of period | 824,880 | 991,835 | ||||||
|
|
|
| |||||
Cash and cash equivalents at end of period | $ | 781,311 | $ | 1,026,139 | ||||
|
|
|
|
WEBMD HEALTH CORP.
NET INCOME PER COMMON SHARE
(In thousands, except per share data, unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Numerator: | ||||||||||||||||
Net income — Basic | $ | 9,716 | $ | 2,611 | $ | 15,982 | $ | 1,073 | ||||||||
Interest expense on 1.50% convertible notes, net of tax | 864 | — | 1,728 | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income — Diluted | $ | 10,580 | $ | 2,611 | $ | 17,710 | $ | 1,073 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Denominator: | ||||||||||||||||
Weighted-average shares — Basic | 37,819 | 49,315 | 38,543 | 49,161 | ||||||||||||
Stock options and restricted stock | 2,301 | 1,610 | 2,443 | 1,014 | ||||||||||||
1.50% convertible notes | 5,681 | — | 5,681 | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Adjusted weighted-average shares after assumed conversions — Diluted | 45,801 | 50,925 | 46,667 | 50,175 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income per common share: | ||||||||||||||||
Basic | $ | 0.26 | $ | 0.05 | $ | 0.41 | $ | 0.02 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted | $ | 0.23 | $ | 0.05 | $ | 0.38 | $ | 0.02 | ||||||||
|
|
|
|
|
|
|
|